Magnesium attenuates methacholine-induced bronchoconstriction in asthmatics

Area of Science:

• Pulmonology
• Pharmacology
• Respiratory Medicine

Background:

• Asthma is a chronic respiratory disease characterized by airway inflammation and hyperresponsiveness.
• Methacholine bronchoprovocation testing (BPT) is a standard method to assess airway hyperresponsiveness.
• Magnesium sulfate (MgSO4) has shown potential in managing asthma exacerbations.

Purpose of the Study:

• To investigate the effect of inhaled magnesium sulfate (MgSO4) on airway hyperresponsiveness in patients with asthma in clinical remission.
• To evaluate the impact of MgSO4 on the methacholine bronchoprovocation test (BPT) in stable asthmatic patients.

Main Methods:

• A double-blind, cross-over study involving 16 asthmatics in clinical remission (FEV1 > 80% predicted).
• Patients underwent methacholine BPT on two separate days, receiving either saline or MgSO4 inhalation prior to the test.
• Spirometry was performed before and after saline or MgSO4, and during the methacholine challenge.

Main Results:

• Inhaled saline or MgSO4 did not significantly alter baseline spirometric measurements.
• A significant inhibition of airway reactivity to methacholine was observed after MgSO4 inhalation (increase in log PD20 FEV1 from 1.31 to 1.56, p < 0.01).
• This indicates reduced bronchial hyperresponsiveness following MgSO4 exposure.

Conclusions:

• Inhaled magnesium sulfate demonstrates a bronchodilatory effect by reducing airway hyperresponsiveness in stable asthmatics.
• The findings suggest that Mg2+ may interfere with calcium handling in bronchial smooth muscle cells, leading to relaxation.
• Inhaled MgSO4 could be a potential therapeutic strategy for managing airway hyperresponsiveness in asthma.